Phibro Animal Health PAHC Proceeds From Long Term Lines Of Credit
Proceeds From Long Term Lines Of Credit at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLongTermLinesOfCredit.
The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phibro Animal Health's proceeds from long term lines of credit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phibro Animal Health's proceeds from long term lines of credit?
- Phibro Animal Health (PAHC) reported proceeds from long term lines of credit of $73M in Q1 2026.
- How has Phibro Animal Health's proceeds from long term lines of credit changed year-over-year?
- Phibro Animal Health's proceeds from long term lines of credit decreased by 9.9% year-over-year, from $81M to $73M.
- What is the long-term trend for Phibro Animal Health's proceeds from long term lines of credit?
- Over 4 years (2021 to 2025), Phibro Animal Health's proceeds from long term lines of credit has grown at a 13.8% compound annual growth rate (CAGR), from $317.5M to $532M.
- What does proceeds from long term lines of credit mean?
- This metric represents the total cash inflows received from drawing down on long-term revolving credit facilities or term loan agreements. It indicates the company's utilization of external debt financing to support liquidity, capital expenditures, or working capital needs. High usage may signal a reliance on debt markets to fund ongoing business activities.